|
1
|
Marsh JC, Goldfarb J, Shafman TD and Diaz
AZ: Current status of immunotherapy and gene therapy for high-grade
gliomas. Cancer Control. 20:43–48. 2013.PubMed/NCBI
|
|
2
|
Chen J and Xu T: Recent therapeutic
advances and insights of recurrent glioblastoma multiforme. Front
Biosci (Landmark Ed). 18:676–684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ajeawung NF, Wang HY and Kamnasaran D:
Progress from clinical trials and emerging non-conventional
therapies for the treatment of Medulloblastomas. Cancer Lett.
330:130–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu Q, Yuan X and Yu JS: Glioma stem cell
research for the development of immunotherapy. Adv Exp Med Biol.
746:216–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Daga A, Bottino C, Castriconi R, Gangemi R
and Ferrini S: New perspectives in glioma immunotherapy. Curr Pharm
Des. 17:2439–2467. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petrosiute A, Auletta JJ and Lazarus HM:
Achieving graft-versus-tumor effect in brain tumor patients: From
autologous progenitor cell transplant to active immunotherapy.
Immunotherapy. 4:1139–1151. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ardon H, Van Gool SW, Verschuere T, Maes
W, Fieuws S, Sciot R, Wilms G, Demaerel P, Goffin J, Van Calenbergh
F, et al: Integration of autologous dendritic cell-based
immunotherapy in the standard of care treatment for patients with
newly diagnosed glioblastoma: Results of the HGG-2006 phase I/II
trial. Cancer Immunol Immunother. 61:2033–2044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prins RM, Wang X, Soto H, Young E, Lisiero
DN, Fong B, Everson R, Yong WH, Lai A, Li G, et al: Comparison of
glioma-associated antigen peptide-loaded versus autologous tumor
lysate-loaded dendritic cell vaccination in malignant glioma
patients. J Immunother. 36:152–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lasky JL III, Panosyan EH, Plant A,
Davidson T, Yong WH, Prins RM, Liau LM and Moore TB: Autologous
tumor lysate-pulsed dendritic cell immunotherapy for pediatric
patients with newly diagnosed or recurrent high-grade gliomas.
Anticancer Res. 33:2047–2056. 2013.PubMed/NCBI
|
|
10
|
Mineharu Y, Muhammad AK, Yagiz K, Candolfi
M, Kroeger KM, Xiong W, Puntel M, Liu C, Levy E, Lugo C, et al:
Gene therapy-mediated reprogramming tumor infiltrating T cells
using IL-2 and inhibiting NF-κB signaling improves the efficacy of
immunotherapy in a brain cancer model. Neurotherapeutics.
9:827–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tobias A, Ahmed A, Moon KS and Lesniak MS:
The art of gene therapy for glioma: A review of the challenging
road to the bedside. J Neurol Neurosurg Psychiatry. 84:213–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Assi H, Candolfi M, Baker G, Mineharu Y,
Lowenstein PR and Castro MG: Gene therapy for brain tumors: Basic
developments and clinical implementation. Neurosci Lett. 527:71–77.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van der Bruggen P, Traversari C, Chomez P,
Lurquin C, De Plaen E, Van den Eynde B, Knuth A and Boon T: A gene
encoding an antigen recognized by cytolytic T lymphocytes on a
human melanoma. Science. 254:1643–1647. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chomez P, De Backer O, Bertrand M, De
Plaen E, Boon T and Lucas S: An overview of the MAGE gene family
with the identification of all human members of the family. Cancer
Res. 61:5544–5551. 2001.PubMed/NCBI
|
|
15
|
Ito S, Kawano Y, Katakura H, Takenaka K,
Adachi M, Sasaki M, Shimizu K, Ikenaka K, Wada H and Tanaka F:
Expression of MAGE-D4, a novel MAGE family antigen, is correlated
with tumor-cell proliferation of non-small cell lung cancer. Lung
Cancer. 51:79–88. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee MH, Son EI, Kim E, Kim IS, Yim MB and
Kim SP: Expression of cancer-testis genes in brain tumors. J Korean
Neurosurg Soc. 43:190–193. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leamon JH, Lee WL, Tartaro KR, Lanza JR,
Sarkis GJ, deWinter AD, Berka J, Weiner M, Rothberg JM and Lohman
KL: A massively parallel PicoTiterPlate based platform for discrete
picoliter-scale polymerase chain reactions. Electrophoresis.
25:11762004. View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Zhang W, Mao XG, Zhen HN, Cao WD
and Hu SJ: Targeting role of glioma stem cells for glioblastoma
multiforme. Curr Med Chem. 20:1974–1984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reardon DA, Wucherpfennig KW, Freeman G,
Wu CJ, Chiocca EA, Wen PY, Curry WT Jr, Mitchell DA, Fecci PE,
Sampson JH and Dranoff G: An update on vaccine therapy and other
immunotherapeutic approaches for glioblastoma. Expert Rev Vaccines.
12:597–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chai Y, Jiang X, Ito Y, Bringas P Jr, Han
J, Rowitch DH, Soriano P, McMahon AP and Sucov HM: Fate of the
mammalian cranial neural crest during tooth and mandibular
morphogenesis. Development. 127:1671–1679. 2000.PubMed/NCBI
|
|
22
|
Hu S, Shen X, Zhang R, Zhang Y, Zhang R,
Zhang W, Deng Z, Cao Y, Zhou Z, Chen J, et al: Development of rat
antigen-presenting cells from pluripotent ecto-mesenchymal stem
cells in vitro and in vivo. Mol Immunol.
45:3818–3826. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Syed ON, Mandigo CE, Killory BD, Canoll P
and Bruce JN: Cancer-testis and melanocyte-differentiation antigen
expression in malignant glioma and meningioma. J Clin Neurosci.
19:1016–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weeraratne SD, Amani V, Neiss A, Teider N,
Scott DK, Pomeroy SL and Cho YJ: miR-34a confers chemosensitivity
through modulation of MAGE-A and p53 in medulloblastoma.
Neuro-oncol. 13:165–175. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang JY, Cao DY, Liu WC, Zhang HM, Teng ZH
and Ren J: Dendritic cell generated from CD34+ hematopoietic
progenitors can be transfected with adenovirus containing gene of
HBsAg and induce antigen-specific cytotoxic T cell responses. Cell
Immunol. 240:14–21. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Candolfi M, King GD, Yagiz K, Curtin JF,
Mineharu Y, Muhammad AK, Foulad D, Kroeger KM, Barnett N, Josien R,
et al: Plasmacytoid dendritic cells in the tumor microenvironment:
Immune targets for glioma therapeutics. Neoplasia. 14:757–770.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kane A and Yang I: Interferon-gamma in
brain tumor immunotherapy. Neurosurg Clin N Am. 21:77–86. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Szabo AT and Carpentier AF: Immunotherapy
in human glioblastoma. Rev Neurol (Paris). 167:668–672. 2011.
View Article : Google Scholar : PubMed/NCBI
|
